Compliance and Regulatory Updates

FDA Regulatory Update – What Makary’s “New FDA” Means for the Life Sciences Industry

FDA’s Vision for Transparency and Accountability The latest FDA regulatory update is drawing attention across the life sciences and government contracting world. Dr. Marty Makary’s vision of a “New FDA” centers on increasing transparency, streamlining the approval process, and promoting stronger accountability in how medical products reach the market. For contractors tied to federal health…

Powell’s Inflation Strategy May Backfire

Powell’s Inflation Strategy May Backfire

Federal Reserve Chair Jerome Powell’s recent comments signal a cautious approach to rate cuts. His speech balanced inflation control with employment softness. This “balanced” stance may seem prudent, but many economists warn it could stall recovery and deepen market uncertainty. “We’re navigating a complex environment where inflation is cooling, but labor markets remain fragile,” Powell…

AI Compute Commoditization -The New Oil

AI Compute Commoditization -The New Oil?

AI computers are no longer just infrastructure. It’s becoming a commodity. Investors are treating GPU cycles and cloud access as tradable assets. This treatment is much like oil futures or spectrum auctions. This shift could reshape how AI startups scale, how cloud providers price services, and how regulators define digital capital. “Compute is the currency…